Navigation Links
Molecular Genetics Research to Fuel Growth in the qPCR and dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc.

San Jose, CA (PRWEB) October 31, 2013

Follow us on LinkedIn - Polymerase chain reaction (PCR) represents one of the fastest growing segments in the life sciences industry. PCR has emerged as a simple yet quick method of DNA amplification and quantification, making it the most commonly used tool in the area of molecular biology. The Human Genome Project and advances in molecular diagnosis and molecular genetics have created significant demand for qPCR and dPCR in a wide range of markets such as drug discovery, disease diagnosis, life sciences research and forensics, among others.

Among various types of PCRs available, qPCR and dPCR instrumentation represent the most sought after and rapidly emerging segments. Although qPCR instrumentation represents a mature sector, existing broad range of applications and emerging new applications transforms it into an indispensible technology for several laboratories worldwide. With new qPCR solutions being developed by large life science companies, demand for qPCR instrumentation continues to rise despite marked decline in prices over the recent years. Gene expression profiling is the largest application of Real-time PCR, with the capability of qPCR to detect, amplify, and quantify DNA and RNA sequences in real time, providing valuable insights to gene expression and genotyping studies. The increasing throughput and multiplexing capabilities of qPCR systems make a strong case for inducting automation robotic systems such as liquid handling robots in the laboratory. This trend is more pronounced among biotech and pharmaceutical companies, government research laboratories and academic centers.

dPCR Instrumentation represents an emerging segment with strong growth led by rising demand from early adopters. Continued technological advancements are expected to benefit demand for dPCR instrumentation in the near-to-mid term. dPCR is gaining popularity for its ability to take nucleic acid quantification and viral detection to the next level. Although dPCR outperforms qPCR in terms of precision, sensitivity, and specificity, qPCR is expected to hold its place in research and testing laboratories for the near term, complemented by dPCR systems. dPCR holds the potential to complement existing qPCR systems in addressing some of the technical challenges faced by virology researchers.

As stated by the new market research report on qPCR and dPCR Instrumentation, the United States represents the largest market worldwide. Japan continues to spearhead global growth with a projected compounded annual growth rate of 10.1% over the period. Education and Research constitutes the largest end-use segment for qPCR and dPCR instrumentation, while Testing Laboratories represents the fastest growing end-use segment.

Major players covered in the report include Agilent Technologies, Bio-Rad Laboratories Inc., Cepheid, Eppendorf AG, Exiqon A/S, F Hoffmann-La Roche Ltd., Fluidigm Corporation, Illumina Inc., Life Technologies Corporation, and RainDance Technologies Inc., among others.

The research report titled “qPCR and dPCR Instrumentation: A Global Strategic Business Report” announced by Global Industry Analysts Inc. provides a comprehensive review of market trends, drivers, challenges, mergers, acquisitions and other strategic industry activities of major companies. The report provides market estimates and projections for qPCR and dPCR Instrumentation in value (US$) for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), Asia-Pacific (China, and Rest of Asia-Pacific), Middle East & Africa, and Latin America. The report also analyzes the global market for qPCR and dPCR Instrumentation by product segments including qPCR and dPCR. End-use segments analyzed include Educational/Research, Testing Laboratories, and Pharma.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. A nano car with molecular 4-wheel drive
2. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
3. Chemists become molecular sculptors, synthesizing tiny, molecular traps
4. Why Medicare Carrier Proposes Major Changes in the Handling of Code Stacked Molecular Test Claims is Topic of December 20 Audio Conference
5. Amsterdam Molecular Therapeutics Announces Negative Equity Position
6. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
7. The art of molecular carpet-weaving
8. Amsterdam Molecular Therapeutics Announces € 2.5 Million Equity Raise
9. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
10. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
11. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. ... (Nasdaq: HART ), a biotechnology company developing bioengineered ... Jim McGorry will present at the LD ... 2015 at 2:30 p.m. PT. The presentation will be ... 30 days. Management will also be available at the ...
(Date:11/25/2015)... Oregon , November 25, 2015 ... Market Research Report is a professional and in-depth ... industry.      (Logo: ) ... overview of the industry including definitions, classifications, applications ... is provided for the international markets including development ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology:
(Date:11/16/2015)... 16, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced expansion of its TDDI product portfolio ... controller and display driver integration (TDDI) solutions designed ... new TDDI products add to the previously-announced ... (WQHD resolution), and TD4322 (FHD resolution) solutions. All ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):